CMS admits no hard data on pharmacy payments
CMS has admitted that it has no hard evidence to back up deputyadministrator Leslie Norwalk's Congressional testimony thatpharmacies are being paid for Part D scripts on a 15-day billingcycle. Instead, Norwalk's assertion was based on informalinformation provided by Part D drug plans.
CMS admits no hard data on pharmacy payments
CMS has admitted that it has no hard evidence to back up deputy administrator Leslie Norwalk's Congressional testimony that pharmacies are being paid for Part D scripts on a 15-day billing cycle. Instead, Norwalk's assertion was based on informal information provided by Part D drug plans. The agency did not ask retail pharmacies about their experiences with slow payments from PBMs administering Part D plans.
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
